GHTC sends FY26 appropriations letters to US appropriators
GHTC sent letters to the relevant appropriations subcommittees in the House and Senate asking them to sustain and protect global health R&D funding in the fiscal year 2026 (FY26) budget
Check out the latest news and announcements from GHTC.
GHTC sent letters to the relevant appropriations subcommittees in the House and Senate asking them to sustain and protect global health R&D funding in the fiscal year 2026 (FY26) budget
GHTC's statement on the formal adoption of the Pandemic Agreement by the World Health Assembly.
Read stories about bright ideas and bold innovations in global health.
As the U.S. Food and Drug Administration (FDA) faces significant staffing reductions, there could be ripple effects for US companies and leadership in the biomedical space, as well as for other countries that depend on the FDA's regulatory leadership to enable access to essential health technologies.
Learn more about upcoming events hosted by or featuring GHTC and its members.
Drugs for Neglected Diseases initiative and World Health Organization
Treatment Action Group